Related Experiment Video
Updated: Jun 10, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular
Balázs Sági1,2, Tibor Vas1, Rita Klaudia Jakabfi-Csepregi3,4
12nd Department of Internal Medicine and Nephrology, Diabetes Center, Clinical Center, Medical School, University of Pécs, Pacsirta Street 1, 7624 Pécs, Hungary.
Insights
High visit-to-visit ultrafiltration variability in hemodialysis patients is linked to worse cardiovascular health, including increased left ventricular hypertrophy and reduced ejection fraction. This suggests a higher cardiovascular risk in these patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular diseases are a leading cause of death in hemodialysis patients.
- Ultrafiltration (UF) variability may contribute to cardiovascular complications.
- Understanding UF's impact is crucial for managing hemodialysis patient health.
Purpose of the Study:
- To investigate the association between visit-to-visit ultrafiltration volume variability (UVSD) and cardiovascular abnormalities in hemodialysis patients.
- To assess the impact of high UVSD on arterial stiffness, cardiac structure, and function.
Main Methods:
- Twenty-nine hemodialysis patients were studied.
- Visit-to-visit ultrafiltration volume variability (UVSD) was calculated over 12 months.
- Measurements included plasma markers (SDC-1, ET-1), applanation tonometry (cfPWV), echocardiography (LVEDD, LVMI, LVEF), and blood pressure.
Main Results:
- High UVSD group showed lower pre-HD cfPWV but increased post-HD cfPWV, indicating more elastic arteries.
- Higher left ventricular end-diastolic diameter (LVEDD) and left ventricular mass index (LVMI) were observed in the high UVSD group.
- Reduced left ventricular ejection fraction (LVEF) and lower pre-HD endothelin-1 (ET-1) levels were found in patients with high UVSD.
Conclusions:
- High UVSD is associated with left ventricular hypertrophy and dysfunction in hemodialysis patients.
- Despite similar fluid removal, high UVSD correlates with adverse cardiac remodeling and reduced LVEF.
- These findings suggest that high UF variability may increase cardiovascular risk in hemodialysis patients.
Abstract:
Background. Cardiovascular (CV) diseases are the most common causes of morbidity and mortality in hemodialysis (HD) patients. We studied the effect of high visit-to-visit ultrafiltration (UF) variability on CV abnormalities in HD patients. Methods. Twenty-nine consecutive patients (age: 65.6 ± 10.4 years) were recruited. Samples for routine lab tests were drawn pre-HD for syndecan-1 (SDC-1) and endothelin-1 (ET-1) measurements pre-, mid- and post-HD. Applanation tonometry was performed pre-, mid- and post-HD. Visit-to-visit ultrafiltration volume variability (UVSD) was calculated as the standard deviation of the UF volume/dialysis session in the preceding 12 months. Echocardiography was performed post-HD. Results. Patients were divided into two groups based on the median of UVSD (500 mL). The average UF volume/HD was not different between the groups. Blood pressure (BP) values were similar. Pre-HD cfPWV (10.75 m/s) was lower in the high UVSD group (14.1 m/s, p = 0.03). In the high UVSD group, post-HD cfPWV (13.9 m/s) was higher than the pre-HD cfPWV (p < 0.05). Pre-HD ET-1 was lower in the high UVSD group (8.6 ± 3.9 vs. 10.8 ± 2.7 pg/mL, p < 0.05). Left ventricular end-diastolic diameter (LVEDD) and left ventricular mass index (LVMI) were higher in the high UVSD group (55.7 ± 7.3 vs. 51.0 ± 5.4 mm and 449.9 ± 180.5 vs. 350.3 ± 85.9 g/m², p < 0.005, respectively). Left ventricular ejection fraction (LVEF) was lower in the high UVSD group (53.5 vs. 60, p < 0.05). Conclusions. High UVSD was associated with increased left ventricular hypertrophy and dysfunction and decreased LVEF compared to low visit-to-visit UV variability despite similar UF volumes temporarily compensated by more elastic arteries. The observed abnormalities may increase CV risk.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations

